Results 131 to 140 of about 1,298,130 (287)

Critical impact of automobile industry with advanced decision support system and Aczél-Alsina Hammy mean operators. [PDF]

Sci Rep
Hussain A, Ullah K, Ali Z, Pamucar D.
europepmc   +1 more source

Conceptual approaches for the formation and implementation of interfaces models of information medical decision support systems

, 2023
Залина Асланбековна Шогенова, Джульетта Абугалиевна Крымшокалова, Муслим Ахметханович Алероев   +2 more
openalex   +1 more source

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

Molecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu, Jianlei Zhao, Aaban Asfar Azmi, Avanti Gupte, Jenna Thibodeau, Shuang Liu, Jinli Yang, Guan Wang, Holly Edwards, Lisa A. Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Julie Boerner, Maik Hüttemann, Jay Yang, Yue Wang, Jeffrey W. Taub, Yubin Ge   +18 more
wiley   +1 more source

Qualitative study on physicians' acceptance of a clinical decision support system for anemia management in patients receiving hemodialysis. [PDF]

BMC Health Serv Res
Yang JY, Cheng SH, Kuo RN.
europepmc   +1 more source

A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression

Molecular Oncology, EarlyView.
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak, Bodee Nutho, Worawat Wattanathana, Narumon Phaonakrop, Bunnatut Panasawatwong, Katharina Erlenbach‐Wuensch, Sittiruk Roytrakul, Regine Schneider‐Stock, Pithi Chanvorachote   +8 more
wiley   +1 more source

Mixed methods evaluation of a clinical decision support system to reduce variation in healthcare. [PDF]

NPJ Digit Med
Pak A, Robertson ST, Nguyen BH, Hodgson T, Sullivan C, Burton-Jones A.   +5 more
europepmc   +1 more source

Decision Support System Mine Problem Solver for Nonlinear Multi-Criteria Analysis [PDF]

, 1986
S. Kaden, Tomasz Kręglewski
openalex  

Adaptaquin is selectively toxic to glioma stem cells through disruption of iron and cholesterol metabolism

Molecular Oncology, EarlyView.
Adaptaquin selectively kills glioma stem cells while sparing differentiated brain cells. Transcriptomic and proteomic analyses show Adaptaquin disrupts iron and cholesterol homeostasis, with iron chelation amplifying cytotoxicity via cholesterol depletion, mitochondrial dysfunction, and elevated reactive oxygen species.
Adrien M. Vaquié, Davod R. Shah, Eliane E. S. Brechbühl, Michael McNicholas, Zhaoyang Xu, John H. Stockley, Laura Morcom, Diana Gold Diaz, Gemma C. Girdler, Rachel V. Seear, Gabriel Balmus, Rajiv R. Ratan, Harry Bulstrode, James A. Nathan, Manav Pathania, Kevin M. Brindle, David H. Rowitch   +16 more
wiley   +1 more source

Hyper-selective explainability: an empirical case study of the utility of explainability in a clinical decision support system. [PDF]

AI Ethics
Duke SA, Sandøe P, Lund TB, Abenavoli EM, Beyer T, Ferrara D, Frille A, Gruenert S, Sabri O, Sciagrà R, Pepponi M, Swen H, Tönjes A, Wirtz H, Yu J, Shiyam Sundar LK, Holm S.   +16 more
europepmc   +1 more source